Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
137 studies found for:    GLP-1R
Show Display Options
Rank Status Study
1 Unknown  DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists
Condition: Diabetes
Intervention: Drug: Exenatide, Liraglutide
2 Recruiting Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus;   Coronary Artery Disease
Interventions: Drug: Liraglutide;   Drug: Metformin
3 Completed Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics
Conditions: Obesity;   Diabetes
Interventions: Drug: BYETTA treatment;   Drug: Metformine
4 Completed
Has Results
GLP1R Polymorphisms and Response to GLP1
Condition: Diabetes
Intervention: Drug: GLP-1
5 Recruiting The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Liraglutide;   Drug: metformin
6 Not yet recruiting Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy
Condition: Obesity
Interventions: Drug: Saxenda;   Drug: Placebos;   Procedure: RYGB
7 Terminated TANTALUS Therapy in Type 2 Diabetic Patients Intolerant or Inadequately Responsive to GLP-1 Receptor Agonist Therapy
Condition: Diabetes Mellitus, Type 2
Intervention: Device: TANTALUS System
8 Recruiting Genomic Study of Dipeptidyl Peptidase-4 (DPP-4) and Glucagon-Like Peptide 1 Receptor (GLP1R) in Chinese and it's Apply in Antidiabetes
Condition: Diabetes Mellitus
Interventions: Drug: Sitagliptin;   Drug: Liraglutide
9 Recruiting The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS
Conditions: Polycystic Ovary Syndrome (PCOS);   Overweight;   Obesity
Interventions: Drug: Metformin-GLP-1 Receptor Agonist;   Drug: Metformin-Oral Contraceptive(OC)
10 Recruiting Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain
Condition: Diabetes Mellitus
Interventions: Drug: Lixisenatide;   Other: Placebo
11 Recruiting Cardiovascular Effects of GLP-1 Receptor Activation
Conditions: Obesity;   PreDiabetes
Interventions: Drug: Liraglutide;   Drug: Sitagliptin;   Other: hypocaloric diet;   Drug: Placebos;   Drug: Exendin (9-39)
12 Completed Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Ipragliflozin
13 Unknown  Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status
Condition: Obesity
Intervention: Drug: Exenatide
14 Completed Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide;   Drug: placebo
15 Completed The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Other: Training and liraglutide;   Other: Training and placebo
16 Recruiting Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: insulin glargine/lixisenatide fixed ratio combination;   Drug: liraglutide;   Drug: exenatide;   Drug: exenatide extended-release;   Drug: albiglutide;   Drug: dulaglutide;   Drug: metformin;   Drug: pioglitazone
17 Not yet recruiting GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes
Conditions: Type2 Diabetes;   Kidney Diseases
Interventions: Drug: Exenatide Extended Release for Inj Susp 2 MG;   Drug: Placebos
18 Active, not recruiting Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: INSULIN GLARGINE (U300);   Drug: Insulin degludec;   Drug: GLP-1 receptor agonist;   Drug: Glimepiride;   Drug: Metformin
19 Completed SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies
Condition: Type 2 Diabetes
Interventions: Drug: Liraglutide;   Drug: Sitagliptin;   Drug: Exenatide;   Drug: Liraglutide placebo;   Drug: Sitagliptin placebo;   Drug: Exenatide placebo;   Drug: L-NMMA
20 Completed The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: insulin degludec/liraglutide;   Drug: liraglutide;   Drug: exenatide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.